[Evaluation of the hematologic changes induced by cis-diamminedichloroplatinum and bleomycin].
D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects*; D001772:Blood Cell Count; D002294:Carcinoma, Squamous Cell / Q000097:blood; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans
D001761:Bleomycin; D002945:Cisplatin
Avaliação des alterações hematológicas pelo uso da cis-diaminodicloroplatina e bleomicina.